MadeAi has launched an artificial intelligence platform called MadeAi Dossier Expert, aimed at assisting pharmaceutical and life sciences companies in developing and maintaining formulary and value dossiers. This platform integrates evidence management, document authoring, and review workflows into a single environment, addressing the complexities involved in preparing AMCP dossiers, global value dossiers, and health technology assessment (HTA) submissions. By facilitating collaboration among various departments such as health economics and outcomes research (HEOR), clinical, market access, and medical writing teams, Dossier Expert aims to streamline the dossier lifecycle.
The platform features AI-generated content based on customizable templates and allows users to verify citations by tracing claims to their source documents. It can identify sections affected by changes in evidence and regenerate content while preserving human edits. MadeAi estimates that Dossier Expert can reduce dossier authoring and update timelines by up to 70%, potentially transforming how evidence materials are prepared for payer discussions and HTA reviews.
Source: drug-dev.com · Image: Naitō Museum of Pharmaceutical Science and Industry 20210529 22 by 先従隗始, CC0, via Wikimedia Commons
Start your 7-day trial and see what the database can do →
